EUDA Health Holdings Ltd has announced an extraordinary general meeting (EGM) set for October 30, 2026, at 9:00 a.m. Eastern U.S. Time. This meeting will focus on important changes to the company’s share structure, including a proposal to increase the maximum number of shares authorized for issuance. This significant move could reshape the company’s capital strategy and is expected to attract attention from investors and competitors alike.
EUDA Health Holdings Ltd, incorporated under the laws of the British Virgin Islands, operates within the health services sector, as indicated by its SIC classification of 8000. The company is listed on the Nasdaq under the tickers EUDA and EUDAW. Recent filings show that EUDA has been active in updating its corporate governance and financial structure, with the latest filing dated October 13, 2026, detailing the upcoming EGM.
The filing states, "In connection with the 2026 Extraordinary General Meeting of the Shareholders, the Company hereby furnishes the Notice and Proxy Statement of the Company’s EGM." This indicates that shareholders will be asked to consider several resolutions aimed at modifying the company’s capital structure.
The key proposals for the EGM include a change to the maximum number of shares authorized for issuance, increasing from an unlimited number of shares of one class to an unlimited number of class A ordinary shares and 2,000,000 class B ordinary shares. Additionally, the company plans to re-designate and re-classify its existing shares, which may affect shareholder rights and voting power.
These changes could have significant implications for existing shareholders and potential investors. By increasing the authorized shares, EUDA may be positioning itself to raise additional capital, which could enhance its operational capabilities and market competitiveness. This move may also be closely monitored by other players in the health services sector, as it reflects broader trends in capital management within the industry.
The filing does not specify what happens next after the EGM, but the outcome of the shareholder votes will be crucial in determining the future direction of the company. Shareholders are encouraged to review the proxy materials available on the company’s website and participate in the upcoming meeting.